| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Michael Edmonds | |
| P2860 | cites work | Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections | Q24240046 |
| Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial | Q31108823 | ||
| Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections | Q33836490 | ||
| Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate | Q34284305 | ||
| Diagnosis and treatment of diabetic foot infections | Q34357233 | ||
| Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. | Q34468030 | ||
| Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes | Q34718540 | ||
| New developments in diagnosing and treating diabetic foot infections | Q34768556 | ||
| Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers | Q34883132 | ||
| Specific guidelines for treatment of diabetic foot osteomyelitis | Q57543698 | ||
| Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? | Q57543717 | ||
| Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate | Q57543731 | ||
| Validation of the Infectious Diseases Society of America's Diabetic Foot Infection Classification System | Q57543736 | ||
| Pathways to diabetic limb amputation. Basis for prevention | Q68809966 | ||
| Diabetic foot disorders. A clinical practice guideline (2006 revision) | Q79726889 | ||
| Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis | Q79902749 | ||
| Foot ulcers and amputations in diabetes | Q80262481 | ||
| Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections | Q80730925 | ||
| Diabetic foot infection | Q81689109 | ||
| A report from the international consensus on diagnosing and treating the infected diabetic foot | Q35777058 | ||
| Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections | Q35871928 | ||
| Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents | Q36098587 | ||
| The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria | Q36381509 | ||
| A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. | Q36440640 | ||
| Systematic review of antimicrobial treatments for diabetic foot ulcers | Q36451493 | ||
| Diabetic foot infections: stepwise medical and surgical management | Q36488312 | ||
| Oral antimicrobial therapy for diabetic foot osteomyelitis | Q36630236 | ||
| New antimicrobial agents as therapy for resistant gram-positive cocci | Q36953330 | ||
| Diabetic foot osteomyelitis | Q37074579 | ||
| Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. | Q37149371 | ||
| Hyperbaric oxygen therapy for wound healing and limb salvage: a systematic review | Q37560085 | ||
| Vancomycin-induced DRESS syndrome in a female patient. | Q40414865 | ||
| Diffusion of ertapenem into bone and synovial tissues. | Q42629280 | ||
| Community acquired MRSA in Europe. | Q42713254 | ||
| The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb | Q43586074 | ||
| Conservative management of osteomyelitis in the feet of diabetic patients | Q44006443 | ||
| Primarily non-surgical management of osteomyelitis of the foot in diabetes | Q44201456 | ||
| An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers | Q44294929 | ||
| Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem | Q44311731 | ||
| Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections | Q44563967 | ||
| Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in old | Q45161084 | ||
| Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections | Q45230598 | ||
| Severe Streptococcus agalactiae infection of the diabetic foot. A deleterious role of Streptococcus agalactiae? | Q45256289 | ||
| Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study | Q46815624 | ||
| Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers | Q46915090 | ||
| In vitro activity of tigecycline against strains isolated from diabetic foot ulcers. | Q46974475 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic | Q12187 |
| β-lactam | Q41873 | ||
| diabetic foot | Q52856 | ||
| ertapenem | Q553220 | ||
| osteomyelitis | Q938983 | ||
| P304 | page(s) | 949-963 | |
| P577 | publication date | 2009-11-16 | |
| P1433 | published in | Vascular Health and Risk Management | Q7916443 |
| P1476 | title | The treatment of diabetic foot infections: focus on ertapenem | |
| P478 | volume | 5 |
| Q47351561 | Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers |
| Q36592698 | Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study |
| Q34065412 | Ertapenem for treatment of osteomyelitis: a case series. |
| Q37788206 | Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections |
Search more.